| Mrs Jan Gillespie-wagner, MD | |
|
1175 58th Ave, Ste 200, Greeley, CO 80634-4807 | |
| (970) 495-0444 | |
| (970) 488-3106 |
| Full Name | Mrs Jan Gillespie-wagner |
|---|---|
| Gender | Female |
| Speciality | Interventional Pain Management |
| Experience | 39 Years |
| Location | 1175 58th Ave, Greeley, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043293921 | NPI | - | NPPES |
| 187075800 | Other | DEPARTMENT OF LABOR | |
| 01267681 | Medicaid | CO | |
| 102189300 | Medicaid | WY | |
| GI160818 | Other | CO | ANTHEM BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 26768 (Colorado) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 26768 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Anesthesia Professional Consultants Llp | 2860474228 | 4 |
News Archive
AstraZeneca today announced top-line results of OSKIRA-4, a Phase IIb monotherapy study of fostamatinib, the first kinase inhibitor with selectivity for SYK (spleen tyrosine kinase) in development as an oral treatment for rheumatoid arthritis (RA).
A research collaboration that combines novel "big-data" informatics tools with expertise in basic biology has uncovered details of an essential process in life: how a crucial enzyme locates the site on DNA where it begins to direct the synthesis of RNA. This finding may aid in the discovery of new antimicrobial medicines, and the powerful technological approaches developed for this research may shed light on other essential cellular processes.
In a paper published in the Nov. 21 issue of Cell, a team led by Mauro Calabrese, a postdoctoral fellow at the University of North Carolina in the lab of Terry Magnuson, chair of the department of genetics and member of the UNC Lineberger Comprehensive Cancer Center, broadens the understanding of how cells regulate silencing of the X chromosome in a process known as X-inactivation.
Researchers found in a study on sheep that giving ewes less food at the time of conception caused DNA changes in the brains of their young. The University of Manchester scientists suspect the findings may hold true for humans as well and could explain why twins are more likely to develop Type 2 diabetes in adulthood.
› Verified 6 days ago
| Entity Name | Intermountain Anesthesia Professional Consultants Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891793022 PECOS PAC ID: 2860474228 Enrollment ID: O20040601001228 |
News Archive
AstraZeneca today announced top-line results of OSKIRA-4, a Phase IIb monotherapy study of fostamatinib, the first kinase inhibitor with selectivity for SYK (spleen tyrosine kinase) in development as an oral treatment for rheumatoid arthritis (RA).
A research collaboration that combines novel "big-data" informatics tools with expertise in basic biology has uncovered details of an essential process in life: how a crucial enzyme locates the site on DNA where it begins to direct the synthesis of RNA. This finding may aid in the discovery of new antimicrobial medicines, and the powerful technological approaches developed for this research may shed light on other essential cellular processes.
In a paper published in the Nov. 21 issue of Cell, a team led by Mauro Calabrese, a postdoctoral fellow at the University of North Carolina in the lab of Terry Magnuson, chair of the department of genetics and member of the UNC Lineberger Comprehensive Cancer Center, broadens the understanding of how cells regulate silencing of the X chromosome in a process known as X-inactivation.
Researchers found in a study on sheep that giving ewes less food at the time of conception caused DNA changes in the brains of their young. The University of Manchester scientists suspect the findings may hold true for humans as well and could explain why twins are more likely to develop Type 2 diabetes in adulthood.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jan Gillespie-wagner, MD 1175 58th Ave, Ste 202, Greeley, CO 80634-4807 Ph: (970) 495-0300 | Mrs Jan Gillespie-wagner, MD 1175 58th Ave, Ste 200, Greeley, CO 80634-4807 Ph: (970) 495-0444 |
News Archive
AstraZeneca today announced top-line results of OSKIRA-4, a Phase IIb monotherapy study of fostamatinib, the first kinase inhibitor with selectivity for SYK (spleen tyrosine kinase) in development as an oral treatment for rheumatoid arthritis (RA).
A research collaboration that combines novel "big-data" informatics tools with expertise in basic biology has uncovered details of an essential process in life: how a crucial enzyme locates the site on DNA where it begins to direct the synthesis of RNA. This finding may aid in the discovery of new antimicrobial medicines, and the powerful technological approaches developed for this research may shed light on other essential cellular processes.
In a paper published in the Nov. 21 issue of Cell, a team led by Mauro Calabrese, a postdoctoral fellow at the University of North Carolina in the lab of Terry Magnuson, chair of the department of genetics and member of the UNC Lineberger Comprehensive Cancer Center, broadens the understanding of how cells regulate silencing of the X chromosome in a process known as X-inactivation.
Researchers found in a study on sheep that giving ewes less food at the time of conception caused DNA changes in the brains of their young. The University of Manchester scientists suspect the findings may hold true for humans as well and could explain why twins are more likely to develop Type 2 diabetes in adulthood.
› Verified 6 days ago
Dr. Phillip A Abston, MD Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1800 15th St, Greeley, CO 80631 Phone: 970-396-2628 Fax: 970-352-4303 |